Cold Chain & Temperature Control in Distribution
A medicine leaves the factory qualified: manufactured, tested, and released to a defined quality. Good Distribution Practice is the discipline that keeps it that way through everything that happens next — storage, handling, and transport across a supply chain that can span continents and change hands many times. Its most technically demanding element is temperature: a product approved to be stored in a defined range is only as good as the coldest and hottest moment it experienced on the way to the patient. Cold-chain control is how the distribution network proves it never let that happen.
What an explainer is not
A topic explainer is SPEQ’s synthesis of what a practice involves, cited to the standards that govern it. It does not reproduce their text, and it does not determine which of them apply to your product or process.
[ POSITION IN THE FRAMEWORK ]
7 DIMENSIONS · 21 LINKSGood Distribution Practice keeps a medicine within its qualified temperature range from factory to patient — a GDP and quality-system responsibility resting hardest on distributors, evidenced by mapping and monitoring in the systems below.
06 · QUALITY MATURITY — COLD CHAIN & TEMPERATURE CONTROL IN DISTRIBUTION, REACTIVE TO ADAPTIVE
Product is shipped in whatever packaging is on hand; excursions are noticed on arrival, if at all, and released or rejected by gut feel.
Storage conditions and monitoring exist, but transport routes and packaging are assumed adequate rather than qualified, and mapping is incomplete.
Storage and transport are temperature-mapped and qualified, monitoring alarms are in place, and every excursion is quarantined and assessed against stability data.
Excursion, monitoring, and lane-performance data are trended so a failing lane or unit is caught before product is compromised.
Stability knowledge and risk shape lane, packaging, and network design; the qualified cold chain is engineered rather than inspected after the fact.
SPEQ’s shared five-stage progression, labelled synthesis — not the FDA QMM rating scale. Where does your organization sit? Score your quality system →
07 · REGULATORY & EVIDENCE
GOVERNING STANDARDS · 3
Derived from the 3 standards SPEQ maps to this subject, across 3 regulatory bodies: EC, WHO, MHRA.
RECORDS & OBJECTIVE EVIDENCE
- Temperature-mapping studies for storage areas and transport configurations
- Continuous temperature-monitoring records with alarm history
- Excursion assessments against stability data with qualified-person disposition
- Qualification records for shipping containers, cold rooms, and transport lanes
- A named Responsible Person and the distributor's GDP quality-system procedures
COMMON INSPECTION FINDINGS
- Temperature excursions dispositioned without a documented stability-based assessment
- Transport routes or packaging used without qualification for actual conditions
- Storage areas not temperature-mapped, so monitoring placement is unjustified
- Monitoring alarms absent, unread, or not investigated
- Handover points (loading dock, courier, receiving) left uncontrolled
Why distribution is a GxP-critical stage
It is tempting to treat distribution as logistics, but the whole point of Good Distribution Practice is that quality does not end at the factory gate. The EU Guidelines on Good Distribution Practice (2013/C 343/01), the WHO GDP guidance (TRS 957, Annex 5), and the MHRA’s GDP standard all make the same demand: a product must reach the patient in the condition the manufacturer qualified, which means the distribution network needs its own quality system — documented procedures, qualified premises, trained people, and a named Responsible Person accountable for compliance.
Distribution is also where the supply chain is most exposed to two failures GDP is written to prevent: a product degraded by conditions it was never qualified for, and a falsified or diverted product entering the legitimate chain. Temperature control addresses the first; provenance controls and the falsified-medicines interface address the second. Both are GDP, and both are inspected.
Temperature control: storage, mapping, and the qualified cold chain
Every medicine carries approved storage conditions — commonly controlled room temperature, refrigerated (about 2–8 °C), or frozen — and GDP requires the network to hold the product within them at every step. That starts with knowing the conditions actually are what they claim to be. Temperature mapping is the study that proves it: sensors placed throughout a storage area (and, increasingly, a transport unit) across representative conditions to find the hot and cold spots before product is ever stored there, so that monitoring can be placed where it matters and the qualified capacity is real rather than assumed.
A qualified cold chain then keeps refrigerated or frozen product in range continuously — qualified refrigerators and cold rooms, validated shipping containers, continuous monitoring with alarms, and the procedures that govern loading, handover, and last-mile delivery. The chain is only as strong as its weakest link, and the links most often missed are the transfers: the loading dock, the courier handover, the pharmacy receiving bay. GDP treats these transitions, not just the fixed storage, as the controlled points.
Excursions: what happens when temperature goes out of range
A temperature excursion is a period during which product experiences conditions outside its approved range. GDP does not treat every excursion as automatic loss of the product, and it does not treat any excursion as ignorable — it requires a defined, documented decision. The excursion must be detected, quarantined, and assessed against stability data: does the specific duration and magnitude, on top of everything else this product has already experienced, still leave it within its qualified conditions? Only a qualified person, on evidence, can release or reject.
The reusable rule mirrors manufacturing deviations: an undocumented excursion decision is the finding, whatever the outcome. Excursion management ties together stability knowledge (from the manufacturer), continuous monitoring data (from the chain), and a disposition record that survives inspection. This is also where distribution and manufacturing meet — the stability data that decides an excursion was generated during development, which is why the two disciplines cannot be treated in isolation.
Transport qualification, the Responsible Person, and provenance
Storage is the easy part because it is fixed; transport is where GDP is hardest, because conditions are variable and control is handed between parties. GDP expects transport routes and packaging configurations to be qualified for the conditions they will actually see — season, duration, mode — rather than assumed adequate, and it holds each party in the chain accountable for maintaining conditions and passing on an intact record. In the EU framework a named Responsible Person carries personal accountability for the distributor’s GDP compliance, the distribution equivalent of a single point of control.
Running alongside temperature is provenance: GDP requires that product move only between authorised parties, with records that let any unit be traced forward and back, so that a recall can reach every affected unit and a falsified product cannot enter unnoticed. Serialisation and falsified-medicines controls sit at this interface. Together, the two halves of GDP — keep the product in condition, and keep the chain of custody clean — are what let a patient trust that the medicine in their hand is the one the manufacturer released.
FREQUENTLY ASKED
What is Good Distribution Practice (GDP)?
GDP is the quality standard for the storage, handling, and transport of medicines through the supply chain, so a product reaches the patient in the condition the manufacturer qualified. It is set out in the EU GDP Guidelines (2013/C 343/01), WHO GDP (TRS 957, Annex 5), and the MHRA GDP standard, and requires distributors to run their own quality system.
What is a temperature excursion?
A temperature excursion is a period during which a product experiences conditions outside its approved storage range. GDP requires the excursion to be detected, quarantined, and assessed against stability data before a qualified person decides — on evidence — whether the product can still be released. An undocumented excursion decision is itself the finding.
What is temperature mapping?
Temperature mapping is a study that places sensors throughout a storage area (or transport unit) across representative conditions to identify hot and cold spots before product is stored there. It proves the qualified conditions are real and shows where continuous monitoring must be placed to be meaningful.
Who is responsible for GDP in the supply chain?
Each party that stores or transports the product is accountable for maintaining its conditions and passing on an intact record. In the EU framework a named Responsible Person carries personal accountability for a distributor’s GDP compliance — the distribution equivalent of a single point of control.